Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 18, 2022 - Issue 1
Submit an article Journal homepage
2,853
Views
1
CrossRef citations to date
0
Altmetric
Novel Vaccines – Short Report

Prediction of serum HIV-1 neutralization titers of VRC01 in HIV-uninfected Antibody Mediated Prevention (AMP) trial participants

Yunda Huanga Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA;b Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA;c Department of Global Health, University of Washington, Seattle, Washington, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-1546-6172View further author information
ORCID Icon,
Lily Zhanga Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USAView further author information
,
Amanda Eatond Duke Human Vaccine Institute, Department of Surgery, Duke University, Durham, North Carolina, USAView further author information
,
Nonhlanhla N. Mkhizee National Institute for Communicable Diseases, Johannesburg, South AfricaView further author information
,
Lindsay N. Carppa Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USAORCID Iconhttps://orcid.org/0000-0003-0333-5925View further author information
ORCID Icon,
Erika Rudnickia Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USAView further author information
,
Allan DeCampa Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USAView further author information
,
Michal Juraskaa Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USAView further author information
,
April Randhawaa Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USAView further author information
,
Adrian McDermottf Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USAView further author information
,
Julie Ledgerwoodf Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USAView further author information
,
Philip Andrewg Family Health International, Durham, North Carolina, USAView further author information
,
Shelly Karunaa Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USAView further author information
,
Srilatha Edupugantih Division of Infectious Diseases, Department of Medicine, Emory University, Decatur, Georgia, USAView further author information
,
Nyaradzo Mgodii Clinical Trials Research Centre, University of Zimbabwe College of Health Sciences, Harare, ZimbabweView further author information
,
Myron Cohenj Department of Medicine, Division of Infectious Diseases, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA;k Institute for Global Health and Infectious Diseases, University of North Carolina, Chapel Hill, North Carolina, USAView further author information
,
Lawrence Coreya Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA;l Departments of Medicine and Laboratory Medicine, University of Washington, Seattle, Washington, USAView further author information
,
John Mascolaf Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USAView further author information
,
Peter B. Gilberta Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA;m Department of Biostatistics, University of Washington, Seattle, Washington, USAView further author information
,
Lynn Morrise National Institute for Communicable Diseases, Johannesburg, South AfricaView further author information
&
David C. Montefiorid Duke Human Vaccine Institute, Department of Surgery, Duke University, Durham, North Carolina, USAView further author information
 show all
Article: 1908030 | Received 18 Nov 2020, Accepted 27 Jan 2021, Published online: 02 Jul 2021

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.